Top

Breast Cancer Research and Treatment

Published in:

01-09-2005 | Report

The Presence of Serum Anti-p53 Antibodies from Patients with Invasive Ductal Carcinoma of Breast: Correlation to Other Clinical and Biological Parameters

Authors: Rui-juan Gao, Hui-zheng Bao, Qiong Yang, Qi Cong, Jin-na Song, Li Wang

Published in: Breast Cancer Research and Treatment | Issue 2/2005

Title: The Presence of Serum Anti-p53 Antibodies from Patients with Invasive Ductal Carcinoma of Breast: Correlation to Other Clinical and Biological Parameters
Authors: Rui-juan Gao
Hui-zheng Bao
Qiong Yang
Qi Cong
Jin-na Song
Li Wang
Publication date: 01-09-2005
Publisher: Kluwer Academic Publishers
Published in: Breast Cancer Research and Treatment / Issue 2/2005
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-005-4321-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2005

Incidence of Male Breast Cancer in California, 1988–2000: Racial/Ethnic Variation in 1759 Men

Inhibition of Either Phosphatidylinositol 3-kinase/Akt or the Mitogen/Extracellular-regulated Kinase, MEK/ERK, Signaling Pathways Suppress Growth of Breast Cancer Cell Lines, but MEK/ERK Signaling is Critical for Cell Survival

Innate Anti-breast Cancer Immunity of Apoptosis-resistant Human γδ-T cells

Patterns of Local and Distant Disease Relapse in Patients with Breast Cancer Treated with Primary Chemotherapy: Do Patients with a Complete Pathological Response Differ from Those with Residual Tumour in the Breast?

The role of X-linked genes in breast cancer

Timely Withdrawal of G-CSF Reduces the Occurrence of Thrombocytopenia During Dose-dense Chemotherapy

Keynote webinar | Spotlight on antibody–drug conjugates in cancer